Pioneer of Next-Generation Sequencing diagnostics for transformative point-of-need applications. Explore our LiDia-SEQ™ platform. #sepsis #BSI #AMR #oncology

Joined April 2011
55 Photos and videos
Pinned Tweet
📣 NEW: Ahead of #AMP2025, DNAe CEO Sam Reed unveils key updates on LiDia-SEQ™, BSI/AMR test & the future of NGS 🧬🚀 Explore real-time diagnostics, decentralised sequencing & bold clinical impact in this exclusive Q&A 🤔 👉 dnae.com/news-posts/dnae-qa-…  #diagnostics #medtech
2
1
177
NEWS: @dna_electronics’ new paper in The Journal of Liquid Biopsy shows progress toward rapid, point‑of‑need NGS ctDNA testing for breast cancer 🧬 👉 Read the study: 🔗 sciencedirect.com/science/ar…  #NGS #Oncology #Diagnostics
40
📸 A big milestone for @DNAe! We’ve received the first samples for Phase One of our Early Access Program 🚀 Our LiDia‑SEQ™ platform brings rapid, point‑of‑need NGS — delivering sample‑to‑result insights in hours. Join the journey: dnae.com/early-access-progra… #diagnostics #AMR
1
2
66
🔍 New DNAe Insights: How rapid, whole‑blood NGS on LiDia‑SEQ™ could save $9K per patient and speed BSI/AMR decisions 🧬🚀 Read more: dnae.com/wp-content/uploads/… #diagnostics #NGS #medtech #sepsis
1
1
1
93
Stay ahead by reading cutting-edge informatics research. @JMDiagn articles showcase tools and computational solutions helping clinical labs analyze, integrate and report complex genomic data. Read here: jmdjournal.org/content/infor…
5
8
280
Clinical NGS momentum was clear at #ESCMID2026. 🚀 mNGS is expanding fast, AI is everywhere, and labs need rapid, actionable results. LiDia‑SEQ™ remains the only near‑patient, sample‑to‑answer NGS platform. 🧬 Posters 👉 dnae.com/news/
1
1
52
ESCMID Global is buzzing and DNAe is right at the centre ✨ Big interest in our LiDia‑SEQ™ data posters 📊 Download: 1️⃣ dnae.com/news-posts/escmid-2…  2️⃣ dnae.com/news-posts/escmid-2… 🔥 Don’t miss tomorrow’s oral session 📅 Apr 21 | 13:30 | Hall ICM 5 #ESCMID2026 #NGS #diagnostics
1
1
137
⏰ NEXT WEEK: DNAe is heading to #ESCMID2026 in Munich! We’re presenting new data from our LiDia‑SEQ™ NGS diagnostic platform hosting oral & poster sessions on rapid pathogen detection and BSI insights. Meet our team 👉 dnae.com/dnae-is-attending-e…  🇩🇪 #NGS #diagnostics
1
1
39
Non‑stop energy at Venture Café London’s Innovation Showcase! Amazing interest in DNAe’s LiDia‑SEQ™ platform our vision for rapid, point‑of‑need diagnostics. Thanks to Venture Café London, ARIA & UCLH Digital Innovation Hub for an inspiring night. 🚀 #healthtech
28
⏰ Today’s the day! Still time to register: 🔗 See you tonight 👋
🚀 DNAe is showcasing its breakthrough NGS diagnostics innovation at @VentureCafeLond this Thu 26 Mar! 🧬 Join us to connect with innovators & explore how LiDia‑SEQ™ is shaping rapid, lab‑free clinical #diagnostics. 📍 1 Triton Sq, LDN ⏰ 6–9pm 🔗 community.venturecafelondon.…
14
⏰ Today’s the day! Still time to register: 🔗 community.venturecafelondon.… See you tonight 👋
🚀 DNAe is showcasing its breakthrough NGS diagnostics innovation at @VentureCafeLond this Thu 26 Mar! 🧬 Join us to connect with innovators & explore how LiDia‑SEQ™ is shaping rapid, lab‑free clinical #diagnostics. 📍 1 Triton Sq, LDN ⏰ 6–9pm 🔗 community.venturecafelondon.…
1
1
31
🚀 DNAe is showcasing its breakthrough NGS diagnostics innovation at @VentureCafeLond this Thu 26 Mar! 🧬 Join us to connect with innovators & explore how LiDia‑SEQ™ is shaping rapid, lab‑free clinical #diagnostics. 📍 1 Triton Sq, LDN ⏰ 6–9pm 🔗 community.venturecafelondon.…
1
1
71
🗓️ NOW BOOKING: Meet @dna_electronics at ESCMID 2026 in Munich! Our team — including CEO Sam Reed and VP Rishi Joshi — will be sharing new data on our NGS‑based LiDia‑SEQ™ platform, from workflow advances to rapid pathogen detection. 🧬 Book: dnae.com/dnae-is-attending-e…#ESCMID
1
1
28
🔍 NEW from DNAe 🧬 @US_FDA is proposing a major shift in oncology companion #diagnostics regulation — moving many CDx tests from Class III (PMA) to Class II (510k). We explain why this could boost innovation while keeping patients protected. 🔬 🔗 dnae.com/news-posts/dnae-ins…
1
1
37
📣 DNAe will present new data on LiDia‑SEQ™ platform & sample‑to‑result NGS #diagnostics at @ESCMID Global in Munich. 🇩🇪 🗣️ Oral: Direct‑from‑sample NGS for rapid BSI ID & AMR   📅 21 Apr • 13:30 📊 Posters on economic impact whole‑blood sepsis assay #ESCMIDGlobal2026
1
1
120
DNAe retweeted
Jan 28
⏰Don't forget to register for #ESCMIDGlobal2026 before early registration ends in two weeks on 11 February. 👀Learn more and register now: ow.ly/VkMK50Y1MXT
2
5
664
AMP Europe connects trans-Atlantic and global experts at the scientific and commercial frontiers of molecular pathology across diverse health systems. Submit an abstract by Feb. 20. Register by March 25 for early-bird pricing. amp-europe-congress.com/
2
5
162
Energised by our recent week at #JPM2026 as we shared progress on LiDia‑SEQ™. ⚡️ Strong VC partner meetings, big interest in our Early Access Program clear momentum across NGS, CDx & point‑of‑care testing. 💪 Thanks to everyone we met — exciting year ahead for DNAe. 🚀
1
3
74
🚀 We’re hiring! 🚀 @dna_electronics is looking for a Senior Product Development Engineer in the US 🇺🇸 Help deliver innovative NGS diagnostics to improve patient care 🏥 💼 1‑year contract 📍 San Jose, CA Apply on LinkedIn 👉 linkedin.com/jobs/view/43304…  #medtech #engineering
1
2
195
We're seeking candidates to fill the available leadership positions within our board of directors, committees and subdivisions. Nominate yourself or a colleague by Jan. 16! Details: amp.org/membership/get-invol…
3
5
194
🚨 DNAe is heading to #JPM2026 in San Francisco 🌉 . Our leadership team will be meeting partners sharing details of our new Early Access Program plus our vision for next‑gen diagnostics. Meet with Sam Reed & Rishi Joshi 👉 dnae.com/dnae-is-attending-j… #JPM2026 #lifesciences
1
1
1
128